Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7168 p451-455
6 October 2001

This article
Reprint
Photocopy


News summary


Concern over traditional Chinese medicines

Consultation has begun on a proposal to extend the list of potent or toxic ingredients which are not permitted in unlicensed herbal medicines.

The current list of ingredients restricted in unlicensed medicines dates from 1977 before the use of traditional Chinese medicines (TCMs) and Ayurvedic (Indian) medicines was widespread in Britain.

The Medicines Control Agency is continuing to find potentially dangerous and illegal ingredients in TCMs. Recently they have been found to include Aristolochia, which was associated with two cases of renal failure in Britain in 1999, mercury and arsenic compounds, and steroids.

Professor Alastair Breckenridge, chairman of the Committee on Safety of Medicines said: “We recognise that many people value herbal remedies, such as traditional Chinese medicines, and are keen that people carry on having the choice to use them. However, there is clear evidence that standards used in the production of some TCMs on the UK market are, at best, unreliable.”

When buying TCMs people should always be aware of the possibility of low quality or illegal products, Professor Breckenridge says. They should not take them if they are not labelled, and do not include a list of ingredients, in English. Even then, clear labelling is not in itself a guarantee of good quality standards.

“Ultimately public confidence in TCMs can only be maintained if the sector itself makes rapid progress in introducing systematic and assured quality controls throughout the supply chain.”

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal